139 related articles for article (PubMed ID: 9592841)
1. Bcl-2 expression and prognosis in childhood acute leukemia. Children's Cancer and Leukemia Study Group.
Tsurusawa M; Saeki K; Katano N; Fujimoto T
Pediatr Hematol Oncol; 1998; 15(2):143-55. PubMed ID: 9592841
[TBL] [Abstract][Full Text] [Related]
2. Clinical relevance of BCL-2 overexpression in childhood acute lymphoblastic leukemia.
Coustan-Smith E; Kitanaka A; Pui CH; McNinch L; Evans WE; Raimondi SC; Behm FG; Aricò M; Campana D
Blood; 1996 Feb; 87(3):1140-6. PubMed ID: 8562940
[TBL] [Abstract][Full Text] [Related]
3. Cellular expression of antiapoptotic BCL-2 oncoprotein in newly diagnosed childhood acute lymphoblastic leukemia: a Children's Cancer Group Study.
Uckun FM; Yang Z; Sather H; Steinherz P; Nachman J; Bostrom B; Crotty L; Sarquis M; Ek O; Zeren T; Tubergen D; Reaman G; Gaynon P
Blood; 1997 May; 89(10):3769-77. PubMed ID: 9160683
[TBL] [Abstract][Full Text] [Related]
4. Cell cycle perturbations in acute myeloid leukemia samples following in vitro exposures to therapeutic agents.
Banker DE; Groudine M; Willman CL; Norwood T; Appelbaum FR
Leuk Res; 1998 Mar; 22(3):221-39. PubMed ID: 9619914
[TBL] [Abstract][Full Text] [Related]
5. Bcl-2 expression in acute myeloblastic leukaemia: relationship with autonomous growth and CD34 antigen expression.
Bradbury DA; Zhu YM; Russell NH
Leuk Lymphoma; 1997 Jan; 24(3-4):221-8. PubMed ID: 9156652
[TBL] [Abstract][Full Text] [Related]
6. Assessment of bcl-2 expression as modulator of fas mediated apoptosis in acute leukemia.
Aref S; Salama O; Al-Tonbary Y; Mansour A
Hematology; 2004 Apr; 9(2):113-21. PubMed ID: 15203866
[TBL] [Abstract][Full Text] [Related]
7. Bcl-2 protein expression in normal human bone marrow precursors and in acute myelogenous leukemia.
Porwit-MacDonald A; Ivory K; Wilkinson S; Wheatley K; Wong L; Janossy G
Leukemia; 1995 Jul; 9(7):1191-8. PubMed ID: 7543174
[TBL] [Abstract][Full Text] [Related]
8. High expression levels of x-linked inhibitor of apoptosis protein and survivin correlate with poor overall survival in childhood de novo acute myeloid leukemia.
Tamm I; Richter S; Oltersdorf D; Creutzig U; Harbott J; Scholz F; Karawajew L; Ludwig WD; Wuchter C
Clin Cancer Res; 2004 Jun; 10(11):3737-44. PubMed ID: 15173080
[TBL] [Abstract][Full Text] [Related]
9. Comparative quantitative expression of bcl-2 by normal and leukaemic myeloid cells.
Bradbury DA; Russell NH
Br J Haematol; 1995 Oct; 91(2):374-9. PubMed ID: 8547078
[TBL] [Abstract][Full Text] [Related]
10. Three-color versus four-color multiparameter cell cycle analyses of primary acute myeloid leukemia samples.
Garrido SM; Willman C; Appelbaum FR; Banker DE
Cytometry; 2000 Apr; 42(2):83-94. PubMed ID: 10797445
[TBL] [Abstract][Full Text] [Related]
11. Expression of BCL-2 proto-oncogene in adult acute lymphoblastic leukemia.
Campos L; Sabido O; Sebban C; Charrin C; Bertheas MF; Fière D; Guyotat D
Leukemia; 1996 Mar; 10(3):434-8. PubMed ID: 8642858
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of BCL-2 oncoprotein and Fas antigen on normal peripheral blood and leukemic bone marrow cells. A flow cytometric analysis.
Molica S; Mannella A; Dattilo A; Levato D; Iuliano F; Peta A; Consarino C; Magro S
Haematologica; 1996; 81(4):302-9. PubMed ID: 8870373
[TBL] [Abstract][Full Text] [Related]
13. ZAP-70 and Bcl-2 expression in B lymphoblastic leukemia cells and hematogones.
Craig FE; Monaghan SA; Surti U; Swerdlow SH
Cytometry B Clin Cytom; 2012 Mar; 82(2):85-92. PubMed ID: 22031455
[TBL] [Abstract][Full Text] [Related]
14. Flow cytometric characterization of phenotype, DNA indices and p53 gene expression in 55 cases of acute leukemia.
Powari M; Varma N; Varma S; Marwaha RK; Sandhu H; Ganguly NK
Anal Quant Cytol Histol; 2002 Jun; 24(3):159-65. PubMed ID: 12102128
[TBL] [Abstract][Full Text] [Related]
15. Quantitative assessment of WT1 expression in diagnosis of childhood acute leukemia.
Spanaki A; Linardakis E; Perdikogianni C; Stiakaki E; Morotti A; Cilloni D; Kalmanti M
Leuk Res; 2007 Apr; 31(4):570-2. PubMed ID: 16876863
[TBL] [Abstract][Full Text] [Related]
16. AC133 expression in egyptian children with acute leukemia: impact on treatment response and disease outcome.
Elgendi HM; Mekawy MA; Abdel Wahab SE; Tawfik LM; Ismail EA; Adly AA
J Pediatr Hematol Oncol; 2010 May; 32(4):286-93. PubMed ID: 20224439
[TBL] [Abstract][Full Text] [Related]
17. Comparison of minimal residual disease (MRD) monitoring by WT1 quantification between childhood acute myeloid leukemia and acute lymphoblastic leukemia.
Zhang R; Yang JY; Sun HQ; Jia H; Liao J; Shi YJ; Li G
Eur Rev Med Pharmacol Sci; 2015; 19(14):2679-88. PubMed ID: 26221900
[TBL] [Abstract][Full Text] [Related]
18. [Expression of bcl-2 in acute leukemia patients and its significance].
Jian ZF; Zhou YH; Chen FP
Hunan Yi Ke Da Xue Xue Bao; 2000 Aug; 25(4):397-8. PubMed ID: 12206015
[TBL] [Abstract][Full Text] [Related]
19. Clinical impact of leukemic blast heterogeneity at diagnosis in cytogenetic intermediate-risk acute myeloid leukemia.
Hoffmann MH; Klausen TW; Boegsted M; Larsen SF; Schmitz A; Leinoe EB; Schmiegelow K; Hasle H; Bergmann OJ; Sorensen S; Nyegaard M; Dybkaer K; Johnsen HE
Cytometry B Clin Cytom; 2012 May; 82(3):123-31. PubMed ID: 22328535
[TBL] [Abstract][Full Text] [Related]
20. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
Pituch-Noworolska A
Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]